<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://pty.alphagenics.co/blog/certificacion-issca-peptidos-medicos/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA: certificación en péptidos y qué aprende el médico</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/champus-milagro-caida-cabello-panama-dermatologos-registro-cosmetico-dnfd/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Champús milagro y caída del cabello en Panamá: qué exige el Minsa</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/china-aprueba-orforglipron-primer-glp1-oral-obesidad/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>China aprueba orforglipron, primer GLP-1 oral para obesidad</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/guia-obesidad-minsa-css-2026-glp1-alerta-ops-panama/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Guía de obesidad Minsa-CSS 2026 y alerta OPS: GLP-1 en Panamá</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/issca-celulas-madre-a-peptidos-medicina-regenerativa/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA: de células madre a péptidos en medicina regenerativa</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/issca-marco-clinico-peptidos-laboratorios-seguimiento/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>ISSCA y péptidos: evaluación, laboratorios y seguimiento</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/mace-peptides-for-veterans-act-ndaa-pentagon-supplement-ban/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Ley PEPTIDES for Veterans y el veto del Pentágono: qué dicen</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/peptidos-solo-para-investigacion-panama-bioetica-cnbi/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>«Solo para investigación» no es autorización: bioética en Panamá</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/retatrutida-sin-registro-panama-alerta-minsa-inyectables-redes/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-12</news:publication_date><news:title>Retatrutida sin registro en Panamá: alerta del Minsa</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/artri-ajo-rey-panama-esteroide-oculto-alerta-minsa/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Artri Ajo Rey en Panamá: esteroide oculto y alerta del Minsa</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/botox-en-crema-argireline-panama-evidencia-registro-cosmetico/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>«Botox en crema» en Panamá: la Argireline, evidencia y marketing</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/cremas-ghk-cu-panama-evidencia-registro-cosmetico-dnfd/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Cremas con GHK-Cu en Panamá: evidencia y registro cosmético</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/glp-1-ra-agonistas-receptor-glp1-que-son/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>GLP-1 RA: qué son los agonistas del receptor de GLP-1</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/minsa-cancela-registros-cosmeticos-bmhca-perfumes-protectores-panama/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Minsa cancela registros cosméticos con BMHCA: qué cambia en Panamá</news:title></news:news></url><url><loc>https://pty.alphagenics.co/blog/rare-glp1r-variants-semaglutide-tirzepatide-helix-ashg-2026/</loc><news:news><news:publication><news:name>Alphagenics Panamá</news:name><news:language>es</news:language></news:publication><news:publication_date>2026-11-11</news:publication_date><news:title>Variantes raras de GLP1R reducen semaglutida, no tirzepatida: ASHG</news:title></news:news></url></urlset>
